Stock & Company Details
EyePoint Pharmaceuticals Inc $EYPT
Price:
46,691,331
84M
$1.1B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
0.00
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
EYPT technical indicators
Latest EyePoint Pharmaceuticals Inc (EYPT) technical indicators as of 2026-07-20: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
41.88 10.4%
MACD:
0.02 82.6%
SMA 50:
$13.24 0.1%
SMA 200:
$14.14 0.1%
EMA 20:
$13.63 0.7%
Bollinger Bands:
15.01 / 12.82
Stochastic:
9.41 49.2%
ADX 14:
13.86 5.1%
ATR 14:
1.00 1.1%
CCI 20:
-185.70 5.1%
OBV:
27.16M 3.9%
ROC 12:
-4.09% 41.5%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
Finance Bot
Ask your questions
Start by typing a question below.
